Active Not Recruiting NA INTERVENTIONAL 6-arm NCT05996783

Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial (ScreenUrSelf)

Sponsor: Antwerp University Hospital (UZA)

Conditions Cervical Intraepithelial Neoplasia Cervix Cancer HPV-Related Cervical Carcinoma Human Papilloma Virus

Interventions Colli-Pee Small Volumes Evalyn Brush

Updated 4 times since 2023 Last updated: Jun 10, 2025 Started: May 25, 2023 Primary completion: Mar 31, 2024 Completion: Sep 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05996783, this NA trial focuses on Cervical Intraepithelial Neoplasia and Cervix Cancer and remains ongoing. Sponsored by Antwerp University Hospital (UZA), it has been updated 4 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Jul 2025 — Present [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Sep 2024 — Jul 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Sep 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

May 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Antwerp University Hospital (UZA)
Centre for Cancer Detection (CvKO)
Sciensano
Universiteit Antwerpen

Data source: Universiteit Antwerpen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edegem, Belgium